Want to see TSE:ASTI full AI Analyst Report?

Aquarius Surgical Technologies (ASTI) Price & Analysis

1 Followers

ASTI Stock Chart & Stats

C$0.01

C$0.00(0.00%)

At close: Dec 06 4:00 PM EST

C$0.01

C$0.00(0.00%)

Day’s Range― - ―

52-Week RangeC$0.01 - C$0.03

Previous CloseN/A

Volume0.00

Average Volume (3M)6.90K

Market Cap

C$275.99K

Enterprise ValueC$6.84M

Total Cash (Recent Filing)C$10.38K

Total Debt (Recent Filing)C$571.18K

Price to Earnings (P/E)―

Beta0.70

Next Earnings

Aug 03, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.04

Shares Outstanding27,599,173

10 Day Avg. Volume4,405

30 Day Avg. Volume6,901

Financial Highlights & Ratios

PEG Ratio>-0.01

Price to Book (P/B)-0.10

Price to Sales (P/S)6.05

P/FCF Ratio-1.44

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Industry Exposure (Medical Devices)Being in the Medical - Devices industry gives the business exposure to structurally stable clinical demand and long product lifecycles. That industry alignment supports a durable addressable market and recurring replacement/upgrade demand over the medium term.

Reported Positive Return On EquityThe balance sheet note of a positive ROE (albeit distorted by negative equity) suggests the company can generate returns on operations. If capital structure is repaired, this operational return profile could help restore sustainable shareholder returns over a multi-month horizon.

Consistent Public Reporting / DisclosureRegular filings and scheduled earnings releases demonstrate governance and reporting discipline. Consistent disclosure supports investor oversight, aids refinancing or strategic options, and preserves access to capital markets when restructuring or funding needs arise.

Bears Say

Declining Revenue And Negative MarginsA sustained ~17% revenue decline alongside negative EBIT/EBITDA and net margins signals structural challenges in demand, pricing or product competitiveness. Persistent top-line erosion plus losses weakens scale economics and hinders investment in commercialization or improvement.

Negative Stockholders' Equity / High LeverageNegative shareholders' equity indicates liabilities exceed assets, creating solvency and leverage risk. This structural balance-sheet weakness limits borrowing capacity, increases refinancing risk and constrains strategic flexibility until capital is recapitalized.

Negative Operating And Free Cash FlowOngoing negative operating and free cash flows demonstrate the business is burning cash from core operations. Persistent cash deficits force reliance on external financing, limit R&D or commercialization spending, and elevate liquidity risk over the medium term.

ASTI FAQ

What was Aquarius Surgical Technologies Inc.’s price range in the past 12 months?

Aquarius Surgical Technologies Inc. lowest stock price was C$0.01 and its highest was C$0.03 in the past 12 months.

What is Aquarius Surgical Technologies Inc.’s market cap?

Aquarius Surgical Technologies Inc.’s market cap is C$275.99K.

When is Aquarius Surgical Technologies Inc.’s upcoming earnings report date?

Aquarius Surgical Technologies Inc.’s upcoming earnings report date is Aug 03, 2026 which is in 21 days.

How were Aquarius Surgical Technologies Inc.’s earnings last quarter?

Aquarius Surgical Technologies Inc. released its earnings results on Feb 24, 2026. The company reported -C$0.021 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.021.

Is Aquarius Surgical Technologies Inc. overvalued?

According to Wall Street analysts Aquarius Surgical Technologies Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Aquarius Surgical Technologies Inc. pay dividends?

Aquarius Surgical Technologies Inc. does not currently pay dividends.

What is Aquarius Surgical Technologies Inc.’s EPS estimate?

Aquarius Surgical Technologies Inc.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Aquarius Surgical Technologies Inc. have?

Aquarius Surgical Technologies Inc. has 27,599,173 shares outstanding.

What happened to Aquarius Surgical Technologies Inc.’s price movement after its last earnings report?

Aquarius Surgical Technologies Inc. reported an EPS of -C$0.021 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of Aquarius Surgical Technologies Inc.?

Currently, no hedge funds are holding shares in TSE:ASTI

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Aquarius Surgical Technologies Inc.

Aquarius Surgical Technologies Inc., operating through its subsidiary Surgical Lasers Inc., specializes in the creation, sale, distribution, and promotion of advanced technological solutions tailored for surgical and other healthcare settings throughout Canada and the United States. The company's core offering comprises sophisticated medical laser systems, catering to a diverse array of specialties such as urology, gynecology, ophthalmology, thoracic surgery, otolaryngology (ENT), cardiovascular procedures, and neurosurgery. Incorporated in 1986, the Toronto, Canada-based firm was previously known as Aquarius Coatings Inc.